Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine the effect of zinc in acute watery diarrhea in children. The investigators will evaluate the effect of product versus placebo.
| Condition | Intervention | Phase |
|---|---|---|
|
Acute Diarrhea Acute Gastroenteritis |
Drug: Zinc Sulfate Other: placebo |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants Under Six Months. |
- duration of diarrheal episode [ Time Frame: five days ] [ Designated as safety issue: Yes ]duration of diarreal episode, time in wich the watery stools will be normalized, an expected average of 5 days.
- duration of hospitalization [ Time Frame: 5 days ] [ Designated as safety issue: Yes ]participants will be followed for the duration of hospital stay, an expected average of 5 days
- weight of stool [ Time Frame: 5 days ] [ Designated as safety issue: Yes ]we expected the weight of the stool will diminish by about 5 days
| Enrollment: | 52 |
| Study Start Date: | July 2011 |
| Study Completion Date: | May 2013 |
| Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: zinc sulfate
zinc sulphate solution.
|
Drug: Zinc Sulfate
zinc sulfate solution, contains 20 mg. per 5 mL. dosage 2.5 mL. per day.
Other Name: Suplizinc
|
|
Placebo Comparator: cornstarch solution
cornstarch powder diluted in distilled water
|
Other: placebo
cornstarch powder diluted in distilled water, dosage 2.5 ml per day
|
Detailed Description:
Background: Acute Gastroenteritis is one of the most and frequent disease in the childhood, today exist strong evidence of beneficial effect of use of zinc in acute diarrhea in children over 6 months. but there are not enough clinical trials to show this beneficial effect on children under 6 months.
Objectives: To evaluate the effect of zinc in the treatment of children under 6 months age with acute diarrhea.
Methods: A randomized clinical trial, controlled, double-blind. The investigators will have two groups of patients : One group will receive zinc plus oral rehydration and the other one will receive placebo plus oral rehydration; the parameters of evaluation are going to be the duration of diarrheal episode, number of diarrhea stools by day, weight of stool, nutritional state.
Eligibility| Ages Eligible for Study: | 1 Month to 6 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- all acute diarrhea
Exclusion Criteria:
- Severe malnourishment
- Severe dehydration
- Systemic infections
- coinfections
Contacts and Locations| Bolivia | |
| Centro Pediatrico Albina Patino | |
| Cochabamba, Bolivia | |
| Study Director: | Giuseppe Grandy, MD MSc | Centro Pediatrico Albina de Patino |
| Study Chair: | Zaida Cama, MD | Centro Pediatrico Albina Ptino |
More Information
No publications provided
| Responsible Party: | Giuseppe Grandy, Medical Chief of Nutrition Center, Centro Pediatrico Albina de Patino |
| ClinicalTrials.gov Identifier: | NCT01571856 History of Changes |
| Other Study ID Numbers: | protzinc2012 |
| Study First Received: | April 3, 2012 |
| Last Updated: | May 5, 2013 |
| Health Authority: | Bolivia: Ethics Committee |
Keywords provided by Centro Pediatrico Albina de Patino:
|
Acute Diarrhea Zinc Children |
Additional relevant MeSH terms:
|
Diarrhea Gastroenteritis Signs and Symptoms, Digestive Signs and Symptoms Gastrointestinal Diseases Digestive System Diseases Zinc Zinc Sulfate |
Trace Elements Micronutrients Growth Substances Physiological Effects of Drugs Pharmacologic Actions Astringents Dermatologic Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 16, 2013